After sliding around the 5 cent per share mark for the first quarter of the year we saw the stock of Innovus Pharmaceuticals Inc (OTCMKTS:INNV) begin to climb the charts in April, but it...
On June 9 the stock of Innovus Pharmaceuticals Inc (OTCMKTS:INNV) soared by more than 50% but it seems that this was nothing more than a one-day bounce – for the past two sessions the ticker...
Innovus Pharmaceuticals Inc. (OTCMKTS:INNV) exploded more than 50% up the charts yesterday, after making two terrific announcements. According to the company’s PR, the clinical tests that the company has been running over the past...
Innovus Pharmaceuticals Inc (OTCMKTS:INNV) had a pretty decent run up the charts last month and managed to gain significant value over a short period of time. Meanwhile, the daily volumes recorded by the company...
The two announcements that Innovus Pharmaceuticals Inc. (OTCMKTS:INNV) made in the very first sessions of this month’s trading managed to purchase it a brief respite, but now it is crashing hard once more. After...
After a period of sliding we saw the stock of Innovus Pharmaceuticals Inc (OTCMKTS:INNV) begin to climb the charts in the beginning of last month and the ticker we up above the 30 cent...
Innovus Pharmaceuticals Inc. (OTCMKTS:INNV) just announced that it has entered into a manufacturing agreement, for FlutiCare™ 60 and 120 spray/bottles. Yes, that’s right – the company just boasted that it has signed an agreement...
Innovus Pharmaceuticals Inc. (OTCMKTS:INNV) took a nasty beating yesterday, losing 28.03% of its market cap in just a couple of hours of trading, but it seems that it is now on its way to...
After a nasty slide in the second half of last month we saw Innovus Pharmaceuticals Inc (OTCMKTS:INNV) climb the charts in May, reaching new heights on increasing daily volumes. The upward movement was...
Yesterday Innovus Pharmaceuticals Inc (OTCMKTS:INNV) issued a new PR reminding investors that it has filed an Abbreviated New Drug Application with the FDA for its FlutiCare nasal spray. According to the company’s expectations a response...